# Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC

> **NCT01265173** · PHASE4 · COMPLETED · sponsor: **Korea University** · enrollment: 261 (actual)

## Conditions studied

- SBP
- Liver Cirrhosis

## Interventions

- **DRUG:** Cefotaxime
- **DRUG:** Ceftriaxone
- **DRUG:** Ciprofloxacin

## Key facts

- **NCT ID:** NCT01265173
- **Lead sponsor:** Korea University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 261 (ACTUAL)
- **Last updated:** 2020-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01265173

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01265173, "Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01265173. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*